EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR)
- 2 September 2012
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 70 (3) , 511-525
Abstract
Identifiable causes of fetal growth restriction (FGR) account for 30 % of cases, but the remainders are idiopathic and are frequently associated with placental dysfunction. We have shown that the angiogenic factor endocrine gland-derived VEGF (EG-VEGF) and its receptors, prokineticin receptor 1 (PROKR1) and 2, (1) are abundantly expressed in human placenta, (2) are up-regulated by hypoxia, (3) control trophoblast invasion, and that EG-VEGF circulating levels are the highest during the first trimester of pregnancy, the period of important placental growth. These findings suggest that EG-VEGF/PROKR1 and 2 might be involved in normal and FGR placental development. To test this hypothesis, we used placental explants, primary trophoblast cultures, and placental and serum samples collected from FGR and age-matched control women. Our results show that (1) EG-VEGF increases trophoblast proliferation ([3H]-thymidine incorporation and Ki67-staining) via the homeobox-gene, HLX (2) the proliferative effect involves PROKR1 but not PROKR2, (3) EG-VEGF does not affect syncytium formation (measurement of syncytin 1 and 2 and β hCG production) (4) EG-VEGF increases the vascularization of the placental villi and insures their survival, (5) EG-VEGF, PROKR1, and PROKR2 mRNA and protein levels are significantly elevated in FGR placentas, and (6) EG-VEGF circulating levels are significantly higher in FGR patients. Altogether, our results identify EG-VEGF as a new placental growth factor acting during the first trimester of pregnancy, established its mechanism of action, and provide evidence for its deregulation in FGR. We propose that EG-VEGF/PROKR1 and 2 increases occur in FGR as a compensatory mechanism to insure proper pregnancy progress.Keywords
This publication has 63 references indexed in Scilit:
- Homeobox Gene HLX Is a Regulator of HGF/c-met-Mediated Migration of Human Trophoblast-Derived Cell Lines1Biology of Reproduction, 2010
- Molecular Characterization of EG-VEGF-mediated Angiogenesis: Differential Effects on Microvascular and Macrovascular Endothelial CellsMolecular Biology of the Cell, 2010
- Role of EG‐VEGF in human placentation: Physiological and pathological implicationsJournal of Cellular and Molecular Medicine, 2008
- Identification and Pharmacological Characterization of Prokineticin 2β as a Selective Ligand for Prokineticin Receptor 1Molecular Pharmacology, 2005
- Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2004
- Structural Determinants Required for the Bioactivities of Prokineticins and Identification of Prokineticin Receptor AntagonistsMolecular Pharmacology, 2004
- Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolutionProceedings of the National Academy of Sciences, 2003
- Direct Involvement of HERV-W Env Glycoprotein in Human Trophoblast Cell Fusion and DifferentiationMolecular and Cellular Biology, 2003
- Identification and Molecular Characterization of Two Closely Related G Protein-coupled Receptors Activated by Prokineticins/Endocrine Gland Vascular Endothelial Growth FactorJournal of Biological Chemistry, 2002
- Inhibition of TGF-β3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnanciesJournal of Clinical Investigation, 1999